NANOFOCUS
DEAD

Serial Number

85080250

Owner

FUJIFILM CORPORATION

Attorney

Doreen L Costa

Filing Date

Jul 8, 2010

Add to watchlist:

No watchlists yet
View on USPTO

NANOFOCUS Trademark

Serial Number: 85080250 • Registration: 4212224

NANOFOCUS is a trademark filed by FUJIFILM CORPORATION on July 8, 2010. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

FUJIFILM CORPORATION (524 trademarks)

26-30, NISHIAZABU 2-CHOME, MINATO-KU
TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

July 8, 2010

Registration Date

September 25, 2012

Published for Opposition

July 10, 2012

Cancellation Date

April 26, 2019

Goods & Services

Pharmaceutical preparations, namely, central nervous system agents, peripheral nervous system agents, sensory organ agents, miscellaneous nervous system and sensory organ agents, cardiovascular agents, respiratory organ agents, digestive organ agents, hormones, urogenital and anal organ agents, epidermides, dental preparations, miscellaneous organ agents, vitamins, nutrients, tonics, blood and body fluid agents, dialysis agents, miscellaneous metabolism agents, cellular function activating agents, antineoplastics, radioactive drugs, allergic agents, miscellaneous cellular function agents, crude drugs and traditional Chinese medicines, antibiotics, chemotherapeutics, biological preparations, parasitics (systemic), pathogenic organism agents, dispensing medicines, intracorporeal diagnostic agents, public health agents, extracorporeal diagnostic agents, non-main therapeutic purpose agents, alkaloidal narcotics, non-alkaloidal narcotics and miscellaneous narcotics; sanitary preparations for medical use; sanitary masks for medical purposes; drug delivery agents in the form of pharmaceutical wafers and gelatin-starch films for providing controlled release of the active ingredients for a wide variety of pharmaceuticals; gauze; empty capsules for pharmaceuticals; eye patches for medical purposes; bandages for skin wounds for use on the ear; sanitary pads; menstruation tampons; sanitary napkins; sanitary panties; cotton for medical purposes; bandages for skin wounds, medical plasters, medical dressings; medical dressing in liquid form, medical dressing containing collodion for pharmaceutical purposes; breast-nursing pads; dental composite materials; incontinence diapers; dietetic lactic sugar for medical use; powdered milk for infants; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing astaxanthin as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing ceramide as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing vitamin E as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing lycopene as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing vitamin C as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing selenium yeast as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing zinc yeast as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing salacia extract powder as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing onion integument extract as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing chitosan as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing apple polyphenol as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing tea catechin as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing chromium yeast as a principal ingredient

Cosmetics; non-medicated toiletries; soaps; detergents for household use; dentifrices, fragrances and perfumery, incenses; false nails; false eyelashes; Anti-static preparations for household purposes; De-greasing preparations for household purposes; rust removing preparations; stain removing preparations; fabric softeners for laundry use; laundry bleaches

Retail store services and wholesale store services featuring pharmaceuticals, sanitary preparations and medical supplies; retail store services and wholesale store services featuring cosmetics and toiletries; retail store services or wholesale store services featuring processed foods; online retail store services and wholesale store services featuring pharmaceuticals, sanitary preparations and medical supplies; online retail store services and wholesale store services featuring cosmetics and toiletries; online retail store services and wholesale store services featuring processed foods; advertising in websites on the Internet; providing businesses information through websites on the Internet; providing consumer products information through websites on the Internet

Chemical powders and emulsifiers for use in the manufacture of health foods and supplements; chemical powders and emulsifiers for use in the manufacture of cosmetics; chemicals for use in the manufacture of pharmaceutical preparations; chemical preparations for general industrial manufacturing

Filing History

CANCELLED SEC. 8 (6-YR)
Apr 26, 2019 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 25, 2017 REM1
REGISTERED-PRINCIPAL REGISTER
Sep 25, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 10, 2012 NPUB
PUBLISHED FOR OPPOSITION
Jul 10, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 20, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 5, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 3, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 10, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 10, 2012 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 7, 2012 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 7, 2011 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 7, 2011 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 7, 2011 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 17, 2011 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 14, 2011 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 14, 2011 GNSL
SUSPENSION LETTER WRITTEN
Apr 14, 2011 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2011 CRFA
ASSIGNED TO LIE
Mar 22, 2011 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 19, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 21, 2010 GNRN
NON-FINAL ACTION E-MAILED
Sep 21, 2010 GNRT
NON-FINAL ACTION WRITTEN
Sep 21, 2010 CNRT
ASSIGNED TO EXAMINER
Sep 13, 2010 DOCK
NOTICE OF PSEUDO MARK MAILED
Jul 13, 2010 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 12, 2010 NWOS
NEW APPLICATION ENTERED
Jul 12, 2010 NWAP